Shares of Coty (NYSE:COTY) traded lower in pre-market trading on Wednesday after TD Cowen analysts downgraded the beauty ...
Fintel reports that on November 13, 2024, TD Cowen downgraded their outlook for Syros Pharmaceuticals (NasdaqGS:SYRS) ...
TD Cowen downgraded Coty (COTY) to Hold from Buy with a price target of $8.50, down from $11. While Coty has a unique business and platform ...
We recently compiled a list of the 13 AI News You Probably Missed. In this article, we are going to take a look at where ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.33% of ...
Kronos Bio (KRON – Research Report) received a Hold rating and price target from TD Cowen analyst Tyler Van Buren yesterday. The ...
Chris Krueger, MD, TD Cowen Washington Research Group, shares his thoughts on Trump’s policies when he takes office again in ...
Shares of investment management firm Onex rose Monday after TD Cowen upgraded the company's outlook on the back of its strong portfolio performance and fundraising. Shares recently traded 6.1% higher ...
Onex Corp. shares are climbing after the Canadian investment firm shed its only neutral rating, with TD Cowen upgrading the ...
TD Cowen on potential opportunities in Canadian equities. The potential impact of Canadian mortgage resets in 2025. Why demographic uncertainty could be a major challenge for the Canadian economy.
TD Cowen analyst Ken Cacciatore raised the firm’s price target on Biohaven (BHVN) to $75 from $55 and keeps a Buy rating on the shares. The firm said they expect Phase III data for T-alfa in SMA ...